HealthTech & BioTech
The most regulated sector deserves the most prepared legal team.
HealthTech and BioTech companies face the highest regulatory stakes in startup law. A HIPAA violation doesn't just mean a fine — it can end your company's ability to operate. FDA regulatory missteps can delay market entry by years. And in a sector where clinical data is both the core asset and the greatest liability, legal infrastructure isn't optional — it's existential.
Key Legal Risks
The most common legal vulnerabilities for HealthTech & BioTech companies — and why they compound fast.
HIPAA violations from improperly designed data architectures or missing Business Associate Agreements
FDA regulatory strategy failures that misclassify medical software or devices
Clinical data ownership disputes in research partnerships with hospitals and academic institutions
Biotech IP protection gaps leaving core research innovations exposed
Missing informed consent frameworks for health data collection and use
International health data transfer violations (EU GDPR has heightened requirements for health data)
Who We Work With
The typical HealthTech & BioTech company that engages Lexium.
Digital health apps, clinical decision support tools, biotech research companies, medical device startups, pharmaceutical platforms, and health data analytics businesses.
We combine regulatory depth with startup speed. Our health frameworks are HIPAA-compliant by design, FDA-pathway aware, and built to survive life science investor due diligence scrutiny.
Legal Services by Priority
The services HealthTech & BioTech companies need most — ranked by urgency and impact.
Data Privacy & Compliance
View serviceHIPAA applies to any entity handling protected health information. Beyond HIPAA, health data triggers the highest protections under GDPR and most state privacy laws. A single misconfigured BAA can result in OCR investigation.
Intellectual Property Protection
View serviceBiotech IP — patents for compounds, processes, diagnostic methods — requires early, strategic filing. University research partnerships add complexity around IP ownership that must be resolved in advance.
Contracts & Commercial Agreements
View serviceBusiness Associate Agreements, clinical study agreements, hospital data sharing contracts, and research collaboration agreements all require specialized drafting that standard templates cannot provide.
Fundraising & Investment Readiness
View serviceLife science investors conduct the most intensive legal due diligence in venture — covering IP chain of title, regulatory status, clinical data rights, and HIPAA compliance before investment.
Company Formation & Structure
View serviceBiotech companies often need specialized structures for managing university license agreements, research subsidiaries, and clinical stage development with strategic partners.
HealthTech & BioTech Legal FAQ
The questions HealthTech & BioTech founders and operators ask us most — answered directly.
Ready to build your HealthTech & BioTech legal foundation?
Let's map your exact legal needs — no obligation, no jargon. Just a direct conversation about where you are and what you need.